Wataru Fukuokaya

38PUBLICATIONS
73CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Sep 21, 2026
Prognostic Stratification in High-Volume Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line Androgen Receptor Pathway Inhibitor-Based Combination Therapy.

|Aug 02, 2026
Clinical Impact of Gleason Pattern 5 on Doublet Versus Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer.

|May 30, 2026
Bayesian Evaluation of Treatment Effect of Avelumab Plus Axitinib for Advanced Renal Cell Carcinoma.

|Apr 17, 2026
Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features.

|Mar 15, 2026
The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line ARPI Therapy.

Takeshi Tsutsumi, Shogo Yamazaki, Takuya Matsuda

|Feb 18, 2026
Real-World Comparative Study of Apalutamide Versus Bicalutamide in Combination With Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer.

Hidetsugu Takahashi, Wataru Fukuokaya, Katsuki Muramoto

Pageof 7

Frequent Collaborators

20 joint publications

Takahiro Kimura

19 joint publications

Takafumi Yanagisawa

19 joint publications

Fumihiko Urabe

17 joint publications

Jun Miki